Inside informationEnglish
NFL Biosciences publishes positive results from a complementary program confirming the excellent safety profile of NFL-101, its first-in-class treatment for tobacco addiction
The file is served by the AMF. We do not host a copy.
Document type
- Issuer
- NFL Biosciences
- Filed
- 04/02/2025, 06:59
- Document type
- Inside information
- AMF sub-type
- Informations privilégiées
- Language
- English
- AMF reference
- 077370_20250204